Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Summary of Keynote Speeches from the 2024 Voice AI Symposium, presented by the Bridge2AI-Voice Consortium.
Patel R, Price N, Bahr R, Bedrick S, Bensoussan Y, Bélisle-Pipon JC, Dorr D, Jackson C, Krussel A, Salvi Cruz S, Toghranegar J, Watts S, Zhao R; Bridge2AI-Voice Consortium; Powell M. Patel R, et al. Among authors: watts s. Front Digit Health. 2024 Dec 3;6:1484503. doi: 10.3389/fdgth.2024.1484503. eCollection 2024. Front Digit Health. 2024. PMID: 39691415 Free PMC article. Review.
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial.
Dark P, Hossain A, McAuley DF, Brealey D, Carlson G, Clayton JC, Felton TW, Ghuman BK, Gordon AC, Hellyer TP, Lone NI, Manazar U, Richards G, McCullagh IJ, McMullan R, McNamee JJ, McNeil HC, Mouncey PR, Naisbitt MJ, Parker RJ, Poole RL, Rostron AJ, Singer M, Stevenson MD, Walsh TS, Welters ID, Whitehouse T, Whiteley S, Wilson P, Young KK, Perkins GD, Lall R; ADAPT-Sepsis Collaborators. Dark P, et al. JAMA. 2024 Dec 9. doi: 10.1001/jama.2024.26458. Online ahead of print. JAMA. 2024. PMID: 39652885
Workshop summaries from the 2024 voice AI symposium, presented by the Bridge2AI-voice consortium.
Bahr R, Anibal J, Bedrick S, Bélisle-Pipon JC, Bensoussan Y, Blaylock N, Castermans J, Comito K, Dorr D, Hale G, Jackson C, Krussel A, Kuman K, Komarlu AR, Lerner-Ellis J, Powell M, Ravitsky V, Rameau A, Reavis C, Sigaras A, Cruz SS, Vojtech J, Urbano M, Watts S, Zhao R, Toghranegar J; Bridge2AI-Voice Consortium. Bahr R, et al. Among authors: watts s. Front Digit Health. 2024 Oct 30;6:1484818. doi: 10.3389/fdgth.2024.1484818. eCollection 2024. Front Digit Health. 2024. PMID: 39540145 Free PMC article. Review.
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Rothman RL, Stewart TG, Mourad A, Boulware DR, McCarthy MW, Thicklin F, Garcia Del Sol IT, Garcia JL, Bramante CT, Shah NS, Singh U, Williamson JC, Rebolledo PA, Jagannathan P, Schwasinger-Schmidt T, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, DeLong A, Wilder R, Collins S, Dunsmore SE, Adam SJ, Hanna GJ, Shenkman E, Hernandez AF, Naggie S, Lindsell CJ; Accelerating COVID-19 Therapeutic Interventions and Vaccines–6 Study Group and Investigators. Rothman RL, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2439332. doi: 10.1001/jamanetworkopen.2024.39332. JAMA Netw Open. 2024. PMID: 39422912 Free PMC article. Clinical Trial.
1,144 results